Solid Biosciences Inc. SLDB Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s accounts payable?
- Solid Biosciences Inc. (SLDB) reported accounts payable of $5.56M in Q1 2026.
- How has Solid Biosciences Inc.'s accounts payable changed year-over-year?
- Solid Biosciences Inc.'s accounts payable decreased by 13.6% year-over-year, from $6.44M to $5.56M.
- What is the long-term trend for Solid Biosciences Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Solid Biosciences Inc.'s accounts payable has grown at a -0.3% compound annual growth rate (CAGR), from $3.27M to $3.22M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.